@article{ATM31482,
author = {Ying Su and Min-Jie Ju and Jie-Fei Ma and Guo-Wei Tu and Hong-Yu He and Zhun-Yong Gu and Yuan-Lin Song and Jing Zhang and Zhe Luo},
title = {Lactate dehydrogenase as a prognostic marker of renal transplant recipients with severe community-acquired pneumonia: a 10-year retrospective study},
journal = {Annals of Translational Medicine},
volume = {7},
number = {22},
year = {2019},
keywords = {},
abstract = {Background: Lactate dehydrogenase (LDH) is an easily accessible biological marker that has been associated with several pulmonary disorders. The aim of this study was to investigate the prognostic value of serum LDH in renal transplant recipients with severe community-acquired pneumonia (CAP).
Methods: A total of 77 renal transplant recipients with severe CAP admitted to the intensive care unit (ICU) were screened for eligibility in this retrospective study. Patient characteristics and laboratory tests, such as LDH on day 1 (LDHday 1) and day 3 (LDHday 3) were recorded. Cox regression models were used to assess the performance of LDH to predict 90-day mortality.
Results: Median LDH level was higher on day 1 in 90-day nonsurvivors (440 U/L, IQR, 362–1,055 U/L) than in survivors (334 U/L, IQR, 265–432 U/L; P},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/31482}
}